ClinicalTrials.gg
Not yet recruitingNCT07667361Updated Jun 25, 2026

Time to Healthy Lifestyle Habit Using Digital Health Tools in Adults at Risk of Diabetes

An interventional study of Hybrid digital intervention with personalized support. and Standard lifestyle education in Prediabetes, sponsored by Imam Abdulrahman Bin Faisal University. Not yet recruiting. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-06-25.

Sponsored by Imam Abdulrahman Bin Faisal University · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
222
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

  1. Background \& Context

    The Challenge: Type 2 Diabetes (T2D) is a major public health burden. Lifestyle changes are effective, but little is known about how long it actually takes to make these changes stick.

    The Gap: Traditional trials look at outcomes at fixed time points (e.g., 12 weeks). We lack data on the specific timeline of habit formation, which is critical for designing scalable interventions.

    The Setting: This study aligns with Saudi Vision 2030 by leveraging digital health to improve population wellness.

  2. Study Objectives

    Primary Aim: To determine if a structured digital intervention accelerates the time to habit adoption compared to standard education.

    Secondary Aims: To measure improvements in glucose control (HbA1c), overall physical activity levels, and quality of life.

  3. Study Design \& Methods

    Design: Randomized Controlled Trial (RCT).

    Population: 222 adults at risk for diabetes.

    Intervention (12 Weeks):

    Group A (Experimental): Hybrid digital intervention with personalized support.

    Group B (Control): Standard lifestyle education.

    Follow-up: Total study duration of 24 weeks.

    Primary Endpoint: "Time to Habit." Defined as achieving ≥150 min/week of moderate-to-vigorous physical activity (MVPA) for four consecutive weeks (verified by wearables).

  4. Statistical Analysis

Primary Analysis: We will use Kaplan-Meier curves to visualize the probability of achieving the habit over time, and Cox Proportional Hazards models to calculate the "Hazard Ratio" (the speed of adoption between the two groups).

Secondary Analysis: General linear models for continuous outcomes (HbA1c, IPAQ, SF-12

02

Conditions studied

  • Prediabetes

Browse trials for

Keywords

  • life style habits
  • prediabetis
  • time to habit formation
03

In context

Prediabetic State

918 studies on the registry are indexed under Prediabetic State; 232 are open to participants now.

This study's planned enrollment of 222 is above the median of 62 across 762 interventional studies indexed under Prediabetic State.

Browse Prediabetic State studies →

Lead sponsor

Imam Abdulrahman Bin Faisal University is the lead sponsor of 91 studies on the registry; 15 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults(18-65 years) Risk of Diabetis

Exclusion criteria

Exclusion Criteria:

  • Dignosed diabetis Pregnancy Any other to exericse praticipation
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
222 participants (estimated)

Study arms

  • Experimental
    Group A

    Other: Hybrid digital intervention with personalized support.

  • Active comparator
    Group B

    Other: Standard lifestyle education

Interventions

  • OtherHybrid digital intervention with personalized support.

    12 Weeks

  • OtherStandard lifestyle education

    Standard lifestyle education for12 weeks

06

What researchers measure

Primary outcomes

  1. Time to Habit Adoption

    Time frame: 12 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jan 2027; primary completion for Dec 2027, 11 months later.

Of 378 non-industry interventional studies with no phase under Prediabetic State, half reached primary completion within 25 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 39. This study's planned 11 months is below that.

Counting every sponsor, half of 424 studies reached it within 23 months; a quarter within 11 and three quarters within 37.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 18, 2026
First posted
Jun 25, 2026
StartEst.
Jan 1, 2027
Primary completionEst.
Dec 30, 2027
CompletionEst.
Jun 30, 2028
Last update
Jun 25, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 25, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07667361
Lead sponsor
Imam Abdulrahman Bin Faisal University
Responsible party
Shibili Nuhmani (Assistant Professor, Imam Abdulrahman Bin Faisal University) — Principal investigator
First posted
Jun 25, 2026
Start date
Jan 1, 2027 (estimated)
Primary completion
Dec 30, 2027 (estimated)
Completion
Jun 30, 2028 (estimated)
Last update
Jun 25, 2026

Study contacts

Shibili Nuhmani, PhD
Contact
snuhmani@iau.edu.sa
00966554270531

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion